Wisconsin Alumni Research Foundation

Therapeutics & Vaccines
Therapeutics Vaccines
Use Of Aryl Hydrocarbon Receptor Ligand As A Therapeutic Intervention In Angiogenesis-implicated Dis
WARF: P06145US

Inventors: Jiasheng Song, Hector DeLuca, Margaret Clagett-Dame, Stuart Helfand, Nasim Akhtar


The Invention
A method of treating angiogenesis-implicated disorders by selecting a subject predisposed to an angiogenesis-implicated disorder and then administering an effective amount of an endogenous aryl hydrocarbon receptor ligand or its analogs according to a formula as disclosed herein is disclosed.
Additional Information
For More Information About the Inventors
For current licensing status, please contact Rafael Diaz at [javascript protected email address] or 608-960-9847

WARF